Clinical Trial Update: A Study to Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas [Phase 1]

View source ↗

Summary

Phase 1 trial assessing whether Onivyde manufactured at two production sites is equivalent in safety and pharmacokinetics for adults with metastatic pancreatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Onivyde (irinotecan hydrochloride liposome injection)

Snippet

Sponsor: Ipsen | Conditions: Metastatic Pancreatic Adenocarcinoma | Phase 1 | Status: COMPLETED